Inhibition by serum of encephalitogenic activity of myelin basic protein: Nature of the serum factor responsible (Q39317380)

11 September 2017

Inhibition by serum of encephalitogenic activity of myelin basic protein: nature of the serum factor responsible (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A46785

6 April 2022

Inhibition by serum of encephalitogenic activity of myelin basic protein: Nature of the serum factor responsible (English)

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

6 April 2022

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

6 April 2022

author name string

C. C. Bernard

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A46785

6 April 2022

G. Lamoureux

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A46785

6 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=46785

6 April 2022

publication date

1 March 1975

1 reference

full work available at URL

11 September 2017

https://api.elsevier.com/content/article/PII:0008874975901975?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

https://api.elsevier.com/content/article/PII:0008874975901975?httpAccept=text/plain

6 April 2022

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

6 April 2022

1 reference

11 September 2017

16

1 reference

11 September 2017

1

1 reference

11 September 2017

182-191

1 reference

The use of globulins as a means of inducing acquired tolerance to parabiotic union

11 September 2017

6

73

848

Karim

1958

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Effect on Antibody Production of Injection of an α2-Protein Fraction

6 April 2022

7

197

1019

Mowbray

1963

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Prolongation of allograft survival by an alpha globulin isolated from normal blood

6 April 2022

8

5

1231

Mannick

1967

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Transformation of human lymphocytes: inhibition by homologous alpha globulin

6 April 2022

9

159

1243

Cooperband

1968

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Immunosuppressive alpha globulin from bovine thymus. I. Preparation and assay

6 April 2022

15

2

425

Carpenter

1971

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Experimental allergic encephalomyelitis. Isolation of basic proteins and polypeptides from central nervous tissue

6 April 2022

19

105

559

Carnegie

1967

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Yield of non-dialyzable mycobacterial constituents during the growth cycle

6 April 2022

26

15

35

Turcotte

1968

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Suppression of allergic encephalomyelitis in rats by means of antibrain serum

6 April 2022

27

117

755

Paterson

1963

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production

6 April 2022

28

136

156

Spitler

1972

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Immunological responses of guinea pigs to a synthetic autoantigen of brain

6 April 2022

29

4

60

Lennon

1974

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Antigen-Associated Immunosuppressant: Effect of Serum on Immune Response

6 April 2022

30

163

290

Whang

1969

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Immunosuppressive activity of serum during the development of experimental allergic encephalomyelitis

6 April 2022

33

11

1

Vanderbark

1974

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation

6 April 2022

35

20

2088

Silk

1967

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Lymphocyte response to P.H.A. in patients with non-lymphoid tumours.

6 April 2022

36

1

618

Garrioch

1970

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Macromolecular inhibitor of lymphocyte transformation in serum from patients with chronic renal failure.

6 April 2022

37

51

259

Nelson

1973

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.

6 April 2022

39

2

1265

Scheuerlen

1971

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Further studies on the mixed leukocyte reaction in multiple sclerosis and various arthritides.

6 April 2022

40

2

291

Hedberg

1973

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Alpha-2-globulins in renal graft rejection. Effects of in vitro lymphocyte function

6 April 2022

41

8

689

Riggio

1969

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

Alpha globulin changes during the development of cellular immunity

6 April 2022

42

8

147

Burger

1973

1 reference

https://api.crossref.org/works/10.1016/0008-8749(75)90197-5

6 April 2022

Identifiers

1 reference

11 September 2017

1 reference